SPCC965.14c Antibody

What is the function of SPCC965.14c in Schizosaccharomyces pombe?

SPCC965.14c encodes a probable cytosine deaminase in fission yeast, which catalyzes the conversion of cytosine to uracil by removing an amino group from cytosine. This enzyme plays a significant role in nucleotide metabolism pathways. Gene expression studies have categorized SPCC965.14c under "Nucleotide metabolism" functions in the fission yeast genome . The protein is primarily involved in pyrimidine salvage pathways, allowing the organism to recycle nucleotides. Cytosine deaminases like the one encoded by SPCC965.14c are critically important enzymes that have applications beyond their natural metabolic roles, including potential uses in detection of epigenetic modifications and genome editing technologies .

What are the structural characteristics of the SPCC965.14c protein?

The SPCC965.14c protein is a predicted cytosine deaminase (EC 3.5.4.1) belonging to the amidohydrolase family. While detailed structural information specific to this particular protein is limited in the current literature, cytosine deaminases typically contain a zinc-binding catalytic domain that facilitates the hydrolytic deamination reaction. The protein structure would likely include binding sites for cytosine substrates and metal cofactors necessary for enzymatic activity. Recent research into diverse cytosine deaminases has revealed remarkable structural diversity among these enzymes, with varying substrate specificities, including those that can act on single-stranded DNA, double-stranded DNA, and those with sequence context preferences .

How are SPCC965.14c antibodies generated and what are their specifications?

SPCC965.14c antibodies are typically produced using antigen-affinity purification methods. Commercial polyclonal antibodies targeting this protein are raised in rabbit hosts with specificity for Schizosaccharomyces pombe (strain 972/24843) . The production process involves immunizing rabbits with purified SPCC965.14c protein or peptide fragments, followed by harvesting and purifying the resulting antibodies. These antibodies are of IgG isotype and undergo quality control testing to ensure specificity against the target protein . Validation is performed using techniques such as ELISA and Western blotting to confirm binding to the native protein and recombinant target .

What applications are SPCC965.14c antibodies suitable for in research settings?

SPCC965.14c antibodies have been validated for multiple research applications including:

• ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative detection of SPCC965.14c in complex biological samples

• Western Blot: For identification of SPCC965.14c protein in cell lysates and tissue extracts

These applications are supported by validation data from commercial providers . While not explicitly documented in the provided references, these antibodies may also be adaptable for immunohistochemistry, immunofluorescence, and immunoprecipitation techniques with appropriate protocol optimization. For reliable experimental outcomes, each application requires specific protocol adjustments regarding antibody concentration, incubation time, and detection methods.

What is the optimal protocol for using SPCC965.14c antibodies in Western blot applications?

For Western blot applications using SPCC965.14c antibodies, researchers should follow this optimized protocol:

• Sample preparation: Lyse S. pombe cells in a buffer containing protease inhibitors, typically using glass bead disruption or chemical lysis methods specific for yeast cells.

• Protein separation: Separate proteins by SDS-PAGE using 10-12% acrylamide gels.

• Transfer: Transfer proteins to a PVDF or nitrocellulose membrane.

• Blocking: Block the membrane with 5% non-fat milk or BSA in TBST for 1 hour at room temperature.

• Primary antibody incubation: Dilute SPCC965.14c antibody (typically 1:1000 to 1:2000) in blocking buffer and incubate overnight at 4°C.

• Washing: Wash membrane 3-4 times with TBST.

• Secondary antibody incubation: Incubate with HRP-conjugated anti-rabbit IgG (typically 1:5000) for 1 hour at room temperature.

• Detection: Develop using enhanced chemiluminescence (ECL) reagents.

The specificity of the antibody should be confirmed by observing a band at the expected molecular weight for SPCC965.14c protein and using appropriate controls including a non-immune rabbit IgG control .

How can researchers validate the specificity of SPCC965.14c antibodies?

Validating the specificity of SPCC965.14c antibodies is crucial for experimental reliability. Recommended validation approaches include:

• Immunodot blot analysis: Test antibody binding to purified SPCC965.14c protein versus control proteins.

• Western blot analysis: Confirm a single band of appropriate molecular weight in yeast cell lysates.

• Knockout/knockdown controls: Compare antibody reactivity in wild-type versus SPCC965.14c-depleted cells.

• Peptide competition assay: Pre-incubate antibody with excess purified SPCC965.14c protein, which should abolish specific signals.

• Cross-reactivity testing: Examine potential cross-reactivity with related proteins or samples from other organisms.

These validation steps are analogous to those demonstrated in rigorous antibody characterization studies, where specificity is confirmed through multiple complementary approaches .

How can SPCC965.14c antibodies contribute to studies of gene expression in fission yeast?

SPCC965.14c antibodies can be instrumental in investigating gene expression patterns in fission yeast under various conditions. In global expression studies examining telomeric DNA loss, SPCC965.14c was identified as part of the nucleotide metabolism category of genes . Researchers can use these antibodies to:

• Track protein expression levels: Quantify SPCC965.14c protein abundance across different growth conditions, stress responses, or mutant strains.

• Correlate protein with mRNA levels: Compare protein expression detected by antibodies with mRNA expression data from techniques like qPCR or RNA-seq.

• Examine post-translational modifications: Investigate potential regulatory modifications of the SPCC965.14c protein.

• Study protein localization: Determine subcellular localization patterns using immunofluorescence techniques.

The table below summarizes expression changes observed in SPCC965.14c in a study examining gene expression changes resulting from telomeric DNA loss:

Note: The values represent differential expression patterns observed in the genetic context tested .

What insights can SPCC965.14c antibodies provide about cytosine deaminase function in relation to DNA modification?

SPCC965.14c antibodies can provide valuable insights into cytosine deaminase function, particularly in the context of DNA modifications. Recent research has highlighted the importance of cytosine deaminases in epigenetic research and genome editing, with different enzymes showing varying specificities for modified cytosines . Using SPCC965.14c antibodies, researchers can:

• Characterize enzyme activity: Determine the substrate specificity of SPCC965.14c by immunoprecipitating the enzyme and performing in vitro deamination assays.

• Identify interaction partners: Use co-immunoprecipitation with SPCC965.14c antibodies to identify proteins that interact with this deaminase.

• Study regulation mechanisms: Examine how SPCC965.14c expression and activity are regulated under different cellular conditions.

• Explore evolutionary relationships: Compare the properties of SPCC965.14c with other cytosine deaminases to understand evolutionary conservation of function.

Recent systematic studies have assayed 175 putative cytosine deaminases on various substrates with epigenetically relevant base modifications, discovering enzymes with diverse activities including CpG-specific deaminases and enzymes that cannot deaminate modified cytosines . Antibodies against SPCC965.14c could help position this enzyme within this functional spectrum.

What are common challenges when working with SPCC965.14c antibodies and how can they be addressed?

Researchers working with SPCC965.14c antibodies may encounter several challenges:

• Low signal intensity:

  • Problem: Weak or undetectable signals in Western blots or immunoassays.

  • Solution: Optimize antibody concentration (try 1:500 instead of 1:1000), increase protein loading, use enhanced detection systems, or extend incubation times.

• High background:

  • Problem: Non-specific binding causing high background noise.

  • Solution: Use more stringent washing steps, optimize blocking conditions (try 5% BSA instead of milk), reduce antibody concentration, or include 0.1-0.5% Tween-20 in washing buffers.

• Cross-reactivity:

  • Problem: Antibody recognizing proteins other than SPCC965.14c.

  • Solution: Increase wash stringency, perform pre-adsorption with non-specific proteins, or validate with additional techniques.

• Variability between experiments:

  • Problem: Inconsistent results between replicate experiments.

  • Solution: Standardize protein extraction methods, use consistent antibody lots, and include internal controls in each experiment.

• Epitope masking:

  • Problem: Protein modifications or interactions blocking antibody binding.

  • Solution: Try alternative lysis buffers, consider native versus denaturing conditions, or test different antibody clones if available.

Each of these challenges requires systematic troubleshooting, similar to approaches used in other antibody characterization studies .

How can researchers differentiate between SPCC965.14c and other related cytosine deaminases?

Distinguishing SPCC965.14c from other related cytosine deaminases requires careful experimental design:

• Sequence alignment analysis: Before experimental work, perform bioinformatic analysis to identify unique regions of SPCC965.14c compared to related deaminases.

• Epitope mapping: Determine the specific region of SPCC965.14c recognized by the antibody and confirm its uniqueness compared to other deaminases.

• Western blot validation: Perform side-by-side Western blot analysis with extracts from different species or strains expressing various deaminases, confirming band size differences.

• Immunodepletion studies: Sequentially deplete samples with antibodies against different deaminases to identify specific versus cross-reactive signals.

• Mass spectrometry confirmation: After immunoprecipitation with SPCC965.14c antibodies, use mass spectrometry to confirm the identity of the captured protein.

The diversity of cytosine deaminases with different substrate specificities highlighted in recent research underscores the importance of proper antibody validation when studying a specific family member .

How can SPCC965.14c antibodies be utilized in studying DNA modification and epigenetic regulation?

SPCC965.14c antibodies can be powerful tools for investigating DNA modification and epigenetic regulation in fission yeast:

• Chromatin immunoprecipitation (ChIP): Determine if SPCC965.14c associates with specific genomic regions, potentially indicating sites of active cytosine deamination.

• Protein complex identification: Use SPCC965.14c antibodies for immunoprecipitation followed by mass spectrometry to identify protein complexes involved in DNA modification.

• Activity correlation studies: Correlate SPCC965.14c protein levels (detected by antibodies) with measurements of cytosine deamination activity in different cellular contexts.

• Developmental regulation: Track SPCC965.14c expression across different developmental stages or stress responses in S. pombe.

Recent research has highlighted the importance of cytosine deaminases in epigenetic modification detection, with some enzymes showing remarkable specificity for different contexts including CpG-specific deamination and sensitivity to modified cytosines . SPCC965.14c antibodies could help determine if this particular deaminase shares these specialized properties.

What potential exists for SPCC965.14c in developing new biotechnological applications?

Based on research into cytosine deaminases, SPCC965.14c holds potential for several biotechnological applications:

• Epigenome mapping tools: If SPCC965.14c shows specific activity on certain cytosine modifications, it could be developed into tools for mapping these modifications, similar to the SEM-seq method developed with another deaminase .

• Genome editing applications: Some cytosine deaminases have been adapted for precision genome editing; SPCC965.14c could potentially be engineered for similar applications.

• Biosensor development: SPCC965.14c antibodies could be incorporated into biosensors for detecting specific nucleotide metabolites or modified bases.

• Therapeutic enzyme development: Understanding SPCC965.14c's specificity could inform the development of therapeutic deaminases for applications in cancer treatment or genetic disease correction.

Recent research has demonstrated that novel cytosine deaminase activities can enable new approaches for nondestructive methylome mapping, including single-enzyme 5-methylcytosine sequencing (SEM-seq) that allows for accurate, high-coverage, base-resolution methylome mapping of scarce biological material . Characterizing SPCC965.14c thoroughly with specific antibodies could reveal whether it possesses unique properties suitable for similar biotechnological innovations.

How does SPCC965.14c compare to other characterized cytosine deaminases?

SPCC965.14c belongs to a diverse family of cytosine deaminases with varying functional properties. A comparative analysis reveals:

• Substrate specificity: While some recently characterized deaminases show high activity on double- and single-stranded DNA in various sequence contexts, including novel CpG-specific activity, the specific activity profile of SPCC965.14c requires further characterization .

• Modification sensitivity: Some cytosine deaminases cannot deaminate modified cytosines, representing a significant functional distinction within this enzyme family . Research using SPCC965.14c antibodies could help determine whether this enzyme shares this property.

• Evolutionary conservation: Comparing SPCC965.14c with deaminases from other species using phylogenetic analysis can provide insights into functional conservation and specialization.

• Structural features: Structural analysis of immunoprecipitated SPCC965.14c could reveal domain organizations similar to or distinct from other characterized deaminases.

The remarkable diversity of cytosine deaminases discovered through systematic assays of 175 putative enzymes highlights the importance of characterizing each family member individually .

What methodological considerations are important when comparing results from different antibodies targeting SPCC965.14c?

When comparing results obtained using different antibodies targeting SPCC965.14c, researchers should consider several methodological factors:

• Epitope differences: Different antibodies may target distinct regions of SPCC965.14c, potentially affecting detection sensitivity if certain epitopes are masked by protein interactions or modifications.

• Production methods: Polyclonal versus monoclonal antibodies will have different specificity profiles, with polyclonal antibodies recognizing multiple epitopes and potentially providing more robust detection .

• Validation standards: Compare the validation methods used for each antibody, including whether specificity was confirmed by techniques such as immunodot blots and Western blot analysis .

• Application optimization: Each antibody may require different optimization for specific applications, including dilution ratios, incubation conditions, and detection methods .

• Cross-reactivity profiles: Consider whether antibodies have been tested for cross-reactivity with related proteins or in different species.

To ensure reliable comparisons, researchers should perform side-by-side testing of different antibodies under standardized conditions, similar to the approach used in comprehensive antibody characterization studies .